Blog
6 tests for assessing cognition in Parkinson’s disease
Cognitive dysfunction in Parkinson’s disease remains a significant, unmet therapeutic need for patients; as such it is vital that there is rigorous research into the topic. Here we will discuss six CANTAB tasks that can address this research gap.
web-based testing,
wearables,
virtual clinical trials,
technology,
swm,
stigma,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
safety,
research funding,
research,
remote testing,
regulations,
recruitment,
rare disease,
prodromal,
pro-cognitive,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient-centric,
patient recruitment,
patient engagement,
parkinson's disease,
pal,
paired associates learning,
ots,
occupational health,
normative data,
neurotech,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
modelling,
mental wellbeing,
mdd,
mci,
major depression,
ied,
high-frequency testing,
high frequency,
healthcare,
guide,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ebt,
ebbinghaus,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive load,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
brain health,
biomarkers,
awards,
automatic speech recognition,
autism,
asr,
asd,
alzheimer's disease,
affective cognition,
adolescents,
absenteeism,
aaic,
